Functional significance of polymorphism among MHC class II gene promoters

Tissue Antigens

Volumn 48, Issue 6, 1996, Pages 615-625

  Guardiola, J ^a   Maffei, A ^a   Lauster, R ^b   Mitchison, N A ^b   Accolla, R S ^c   Sartoris, S ^d  

^a Ist Internazionale Genet e Biofis   (Italy)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c University of Varese   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Gene promoter; Polymorphism

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ANTIGEN PRESENTING CELL; DNA POLYMORPHISM; GENE EXPRESSION; GENE LOCUS; HELPER CELL; HETEROZYGOTE; HUMAN; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; T LYMPHOCYTE;

EID: 0030448909     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02684.x     Document Type: Review

References (114)

1. Matis LA, Glimcher LH, Paul WE, Schwartz RH. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A 1983: 80: 6019-23.
2. Tite JP, Janeway CA Jr. Antigen-dependent selection of B lymphoma cells varying in Ia density by cloned antigen-specific L3T4a+ T cells: a possible in vitro model for B cell adaptive differentiation. J Mol Cell Immunol 1984: 1: 253-65.
3. Janeway C, Bottomly K, Babich J et al. Quantitative variation in Ia expression plays a central role in immune regulation. Immunol Today 1984: 5: 99-105.
4. Parish CR, Liew FY. Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med 1972: 135: 298-311.
5. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992: 257: 539-42.
6. Tite JP, Foellmer HG, Madri JA, Janeway CA Jr. Inverse Ir gene control of the antibody and T cell proliferative responses to human basement membrane collagen. J Immunol 1987: 139: 2892-8.
7. Pfeiffer C, Murray J, Madri J, Bottomly K. Selective activation of Th1- and Th2-like cells in vivo - response to human collagen IV. Immunol Rev 1991: 123: 65-84.
8. Murray JS, Pfeiffer C, Madri J, Bottomly K. Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur J Immunol 1992: 22: 559-565.
9. Murray JS, Madri J, Pasqualini T, Bottomly K. Functional CD4 T cell subset interplay in an intact immune system. J Immunol 1993: 150: 4270-6.
10. Mitchison NA, Brunner MC, Schneider SC. Tolerance-of-self and protection against autoimmunity. In: Musafa AS, Al-Attiyah RRJ, Nath I, Chug TD, ed. T-cell subsets and cytokine interplay in infectious diseases. Basel: Karger, 1996: 1-17.
11. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 1995: 182: 1579-84.
12. + T cells. J Exp Med 1995: 182: 1591-6.
13. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995: 2: 555-9.
14. + T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 1995: 182: 5-13.
15. Faltynek CR, Wang S, Miller D et al. Inhibition of T lymphocyte activation by a novel p561ck tyrosine kinase inhibitor. J Enzym Inhib 1995: 9: 111-22.
16. Hanke JH, Gardner JP, Dow RL et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996: 271: 695-701.
17. Britz JS, Jason JM, Ptak W, Janeway CA Jr, Gershon RK. Distinctive immunological properties of cultured murine thymic epithelial cells. Clin Immunol Immunopathol 1984: 30: 227-32.
18. Janeway CA Jr, Ron J, Katz ME. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol 1987: 138: 1051-5.
19. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev 1989: 111: 79-110.
20. Schmitz J, Assenmacher M, Radbruch A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol 1993: 23: 191-9.
21. Stockinger B, Zal T, Zal A, Gray D. B cells solicit their own help from T cells. J Exp Med 1996: 183: 891-899.
22. Mason D. The role of B cells in the programming of T cells for IL-4 synthesis. J Exp Med 1996: 183: 717-718.
23. + T cells. J Immunol 1995: 154: 5071-9.
24. Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P. Successful T cell priming in B cell-deficient mice. J Exp Med 1995: 182: 915-22.
25. + T cells to protein antigens in vivo. Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. J Immunol 1995: 155: 3734-41.
26. Inaba K, Steinman RM, Pack MW et al. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992: 175: 1157-67.
27. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994: 179: 1109-18.
28. Latron F, Jotterand BM, Maffei A et al. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc Natl Acad Sci U S A 1988: 85: 2229-33.
29. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992: 10: 13-49.
30. Beaty JS, West KA, Nepom GT. Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1. Mol Cell Biol 1995: 15: 4771-82.
31. Streit WJ, Graeber MB, Kreutzberg GW. Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 1989: 21: 117-123.
32. Schwartz RH. T-lymphocyte recognition of antigen is associated with gene products of the major histocompatibility complex. Annu Rev Immunol 1985: 3: 237-261.
33. Oliveira DB, Blackwell N, Virchis AE, Axelrod RA. T helper and T suppressor cells are restricted by the A and E molecules, respectively, in the F antigen system. Immunogenetics 1985: 22: 169-75.
34. Oliveira DB, Mitchison NA. Immune suppression genes. Clin Exp Immunol 1989: 75: 167-77.
35. Gonzalez-Gay MA, Nabozny GH, Bull MJ et al. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J Exp Med 1994: 180: 1559-64.
36. Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 1987: 327: 426-30.
37. Sasazuki T. Immunological recognition. Cold Spring Harbor Symp Quant Biol 1989: 54: 69-74.
38. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A. HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993: 53: 150-67.
39. Asherson GL, Dieli F, Gautam Y, Siew LK, Zembala M. Major histocompatibility complex regulation of the class of the immune response: the H-2d haplotype determines poor interferon-gamma response to several antigens. Eur J Immunol 1990: 20: 1305-10.
40. Dieli F, Sireci G, Lio D, Bonanno CT, Salerno A. Major histocompatibility complex regulation of interleukin-5 production in the mouse. Eur J Immunol 1993: 23: 2897-902.
41. Mitchison NA, Brunner MC. Association of H2Ab with resistance to collagen-induced arthritis in H2-recombinant mouse strains: an allele associated with reduction of several apparently unrelated responses. Immunogenetics 1995: 41: 239-45.
42. Brunner MC, Larsen S, Sette A, Mitchison NA. Altered Th1/Th2 balance associated with the immunosuppressive/ protective effect of the H-2Ab allele on the response to allo-HPPD. Eur J Immunol 1995: 25: 3285-3289.
43. Thomson G, Robinson WP, Kuhner MK et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988: 43: 799-816.
44. Paul C, Haas JP, Schoenwald U et al. HLA class I/class II interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 1994: 39: 61-4.
45. Jaraquemada D, Ollier W, Awad J et al. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986: 45: 627-36.
46. Stastny P, Ball EJ, Khan MA, Olsen NJ, Pincus T, Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol 1988: 2: 132-8.
47. Lang B, Melchers I, Urlacher A et al. HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients. Rheumatol Int 1990: 10: 171-5.
48. Paul C, Schoenwald U, Truckenbrodt H et al. HLA-DP/ DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 1993: 37: 442-8.
49. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991: 38: 1-15.
50. Haegert DG, Francis GS. Contribution of a single DQ beta chain residue to multiple sclerosis in French Canadians. Hum Immunol 1992: 34: 85-90.
51. Allen M, Sandberg-Wollheim M, Sjögren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994: 39: 41-8.
52. Nepom GT. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990: 39: 1153-7.
53. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993: 11: 729-66.
54. Böhme J, Brenden N, Rietz C, Pilström B. Dominant disease protection in MHC-transgenic NOD mice. More than one mechanism? Immunologist 1995: 3: 45-58.
55. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995: 82: 155-65.
56. Reich EP, Sherwin RS, Kanagawa O, Janeway CA, Jr. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature 1989: 341: 326-8.
57. Gonzalez-Gay MA, Zanelli E, Krco CJ et al. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics 1995: 42: 35-40.
58. Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995: 16: 274-8.
59. Sette A, Southwood S, Miller J, Appella E. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J Exp Med 1995: 181: 677-83.
60. Hughes AL, Nei M. Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc Natl Acad Sci U S A 1989: 86: 958-62.
61. Lauster R. Accession number X86147-X86156. EMBL nucleotide sequence bank 1995.
62. Schwiebert LM, Hughes A, Monos DS, Ono SJ. HLA-DRA promoter polymorphism and diversity generation within the immune system. Immunogenetics (in press).
63. Daser A, Mitchison H, Mitchison A, Müller B. Non-classical-MHC genetics of immunological disease in man and mouse. The key role of proinflammatory cytokine genes. Cytokine (in press).
64. Benoist C, Mathis D. Regulation of major histocompatibility complex class II genes: X and Y and other letters of the alphabet. Annu Rev Immunol 1990: 8: 681-715.
65. Cogswell JP, Basta PV, Ting JP-Y. Proc Natl Acad Sci U S A 1990: 87: 7703-7707.
66. Gönezy P, Reith W, Barras E et al. Mol Cell Biol 1989: 9: 296-302.
67. Sartoris S, Accolla RS. Transcriptional regulation of MHC class II genes. Int J Clin Lab Res 1995: 25: 71-78.
68. Reith W, Steimle V, Mach B. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today 1995: 16: 539-546.
69. Woolfrey AE, Nepom GT. Differential transcription elements direct expression of HLA-DQ genes. Clin Immunol Immunopathol 1995: 74: 119-26.
70. Abdulkadir SA, Ono SJ. How are class II MHC genes turned on and off? FASEB J 1995: 9: 1429-35.
71. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993: 75: 135-46.
72. Kovats S, Nepom GT, Coleman M, Nepom B, Kwok WW, Blum JS. Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J Clin Invest 1995: 96: 217-23.
73. Kobr M, Reith W, Herrero-Sanchez C, Mach B. Mol Cell Biol 1990: 10: 965-971.
74. Boothby M, Lioti HC, Glimcher LH. Differences in DNA sequence specificity among MHC class II X box binding proteins. J Immunol 1989: 142: 1005-14.
75. De Lerma Barbara A, Rigaud G, Sartoris S, Nicolis M, Cesturi T, Accolla RS. Divergent evolution in the mechanisms controlling major histocompatibility complex class II gene transcription in mouse and human. Eur J Immunol 1996: 26: 259-62.
76. De Lerma Barbaro A, Sartoris S, Tosi G, Nicolis M, Accolla RS. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules. J Immunol 1994: 153: 4530-8.
77. Woolfrey AE, Andersen LC, Shewey L, Chung J, Nepom GT. Analysis of differential HLA-DQB expression in autologous B cell lines. J Leukoc Biol 1993: 53: 697-706.
78. Emery P, Mach B, Reith W. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum Immunol 1993: 38: 137-47.
79. Auffrray C, Lillie JW, Korman AJ et al. Structure and expression of the HLA-DQa and -DXa genes: interallelic alternate splicing of the HLA-DXa gene using a retroviral vector. Immunogenetics 1987: 26: 63-73.
80. Yu LP, Sheehy MJ. The cryptic HLA-DQA2 ("DX alpha") gene is expressed in human B cell lines. J Immunol 1991: 147: 4393-7.
81. Kimura A, Sasazuki T. Polymorphism in the 5′ Hanking region of the HLA-DQA1 gene and its relation to the DR-DQ haplotype. In: Tsuji K, Aizaka M, Aizawa M, ed. HLA 1991, vol. 2. Oxford: Oxford University Press, 1992: 382-385.
82. Morzycka WE, Harwood JI, Smith JR, Kagnoff MF. Structure and evolution of the promoter regions of the DQA genes. Immunogenetics 1993: 37: 364-72.
83. Kimura A, Sasazuki T. HLA-DQA gene is differently regulated from other HLA class II genes. In: Yooshida TO, Wilson JM, ed. Molecular approaches to the study and treatment of human disease. Amsterdam: Elsevier, 1992, 97-104.
84. Voliva CF, Tsang S, Peterlin BM. Mapping cis-acting defects in promoters of transcriptionally silent DQA2, DQB2, DOB genes. Proc Natl Acad Sci U S A 1993: 90: 3408-12.
85. Pinet V, Eliaou JF, Clot J. Description of a polymorphism in the regulatory region of the HLA-DRA gene. Hum Immunol 1991: 32: 162-9.
86. Louis P, Eliaou JF, Kerlan CS, Pinet V, Vincent R, Clot J. Polymorphism in the regulatory region of HLA-DRB aenes correlating with haplotype evolution. Immunogenetics 1993: 38: 21-6.
87. Perfetto C, Zacheis M, McDaid D, Meador J, Schwartz BD. Polymorphism in the promoter region of HLA-DRB genes. Hum Immunol 1993: 36: 27-33.
88. Singal DP, D'Souza M, Sood SK, Qiu X. Sequence-specific interactions of the nuclear proteins with polymorphic upstream regulatory regions of HLA-DRB genes. Transplant Proc 1993: 25: 180-182.
89. Andersen LC, Beaty JS, Nettles JW, Seyfried CE, Nepom GT, Nepoorn BS. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes. J Exp Med 1991: 173: 181-92.
90. Reichstetter S, Krellner PH, Meenzen CM, Kalden JR, Wassmuth R. Comparative analysis of sequence variability in the upstream regulatory region of the HLA-DQB1 gene. Immunogenetics 1994: 39: 207-12.
91. Sukiennicki TL, Shewey LM, Nepom GT. Locus- and allele-specific DNA-protein interactions in the HLA-DQB1 X box. Immunol Res 1993: 12: 317-29.
92. Del Pozzo G, Perfetto C, Ombra MN, Ding GZ, Guardiola J, Maffei A. DNA polymorphisms in the 5′-flanking region of the HLA-DQA1 gene. Immunogenetics 1992: 35: 176-82.
93. Partanen J, Peterson P, Westman P, Aranko S, Krohn K. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum Immunol 1994: 41: 135-40.
94. Haas JP, Kimura A, Andreas A et al. Polymorphism in the upstream regulatory region of DQA1 genes and DRB1, QAP, DQA1, and DQB1 haplotypes in the German population. Hum Immunol 1994: 39: 31-40.
95. Maffei A, Reed EF, McManus P, Guardiola J, Suciu-Foca N. RFLP characterization of the upstream regulatory region of the HLA-DQA1 gene. Tissue Antigens 1994: 43: 95-101.
96. Carson S, Wiles MV. Far upstream regions of class II MHC Ea are necessary for position-independent, copy-dependent expression of Ea transgene. Nucleic Acids Res 1993: 21: 2065-2072.
97. Jones PP, Murphy DB, McDevitt HO. Two-gene control of the expression of a murine Ia antigen. J Exp Med 1978: 148: 925-939.
98. Charron DJ, McDevitt HO. Analysis of HLA-D region-associated molecules with monoclonal antibody. Proc Natl Acad Sci U S A 1979: 76: 6567-71.
99. Moosic JP, Nilson A, Hammerling GJ, McKean DJ. Biochemical characterization of Ia antigens. I. Characterization of the 31K polypeptide associated with I-A subregion Ia antigens. J Immunol 1980: 125: 1463-9.
100. Pierres M, Lafuse WP, Dosseto M, Devaux C, Birnbaum DZ, David CS. Molecular specificity of a monoclonal anti-Ik alloantibody identifying a highly conserved determinant on mouse I-A, I-E and human DR antigens. Tissue Antigens 1982: 20: 208-20.
101. Lafuse WP, Corser PS, David CS. Biochemical evidence for multiple I-E Ia molecules. Immunogenetics 1982: 15: 365-75.
102. Brown PH, Mathis D, Cone RE, Jones PP, Ponzio NM, Thorbecke GJ. Properties of reticulum cell sarcomas in SJL/J mice. VIII. Prominent role of RCS cell I-A antigens in the stimulation of syngeneic T cells. Immunogenetics 1983: 18: 399-413.
103. Singh SK, Donovan KA, David CS. Transcriptional control of MHC class II antigen expression on mouse T cell lines. J Immunogenet 1986: 13: 187-94.
104. Sharrow SO, Ozato K, Sachs DH. Phenotypic expression of I-A and I-E/C subregion determinants on murine thymocytes. J Immunol 1980: 125: 2263-8.
105. Louis P, Vincent R, Cavadore P, Clot J, Eliaou J-F. Differential transcriptional activities of HLA-DR genes in the various haplotypes. J Immunol 1994: 153: 5059-5067.
106. Louis P, Pinet V, Cavadore P et al. Differential expression of HLA-DRB genes according to the polymorphism of their regulatory region. Differential transcriptional activities of HLA-DR genes in the various haplotypes. C R Acad Sci III 1994: 317: 161-6.
107. Shewey LM, Beaty JS, Andersen LC, Nepom GT. Differential expression of related HLA class II DQ beta genes caused by nucleotide variation in transcriptional regulatory elements. J Immunol 1992: 148: 1265-73.
108. Nepom GT, Chung J, West KA. Differential expression of HLA-DQB1 alleles in a heterozygous cell line. Immunogenetics 1995: 42: 143-8.
109. Vincent R, Louis P, Gongora C, Papa I, Clot J, Eliaou J-F. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction. J Immunol 1996: 156: 603-610.
110. Cereb N, Yang SY. The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation. J Immunol 1994: 152: 3873-3883.
111. Yao Z, Volgger A, Scholz S, Albert ED. Sequence polymorphism in the HLA-B promoter region. Immunogenetics 1995: 41: 343-353.
112. Kaufman J, Volk H, Wallny HJ. A "minimal essential Mhc" and an "unrecognized Mhc": two extremes in selection for polymorphism. Immunol Rev 1995: 143: 63-88.
113. Fleury S, Thibodeau J, Croteau G, Labrecque N, Aronson HE, Cantin C, Long EO, Sekaly RP. HLA-DR polymorphism affects the interaction with CD4. J Exp Med 1995: 182: 733-41.
114. Janitz M, Mitchison A, Reiners-Schramm L, Lauster R. Polymoprphic MHC class II promoters exhibit distinct expression pattern in various antigen presenting cell lines. Tissue Antigens (in press).